Vancomycin associated with higher mortality in MRSA bloodstream infections.
New findings published in Clinical Infectious Diseases indicate that increased vancomycin minimum inhibitory concentration was associated with a higher mortality rate in patients with methicillin-resistant Staphylococcus aureus bloodstream infections. “Thus, institutions should consider conducting Etest minimum inhibitory concentration (MIC) on all methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections isolates,” Sebastiaan J. van Hal, FRACP, FRCPA, of the University of Western Sydney, Australia, and colleagues wrote in the study.
